-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Initiates Coverage On Context Therapeutics with Buy Rating, Announces Price Target of $7

Benzinga·12/22/2025 12:25:04
Listen to the news
Jones Trading analyst Soumit Roy initiates coverage on Context Therapeutics (NASDAQ:CNTX) with a Buy rating and announces Price Target of $7.